Cargando…
Is Glial Dysfunction the Key Pathogenesis of LRRK2-Linked Parkinson’s Disease?
Leucine rich-repeat kinase 2 (LRRK2) is the most well-known etiologic gene for familial Parkinson’s disease (PD). Its gene product is a large kinase with multiple functional domains that phosphorylates a subset of Rab small GTPases. However, studies of autopsy cases with LRRK2 mutations indicate a v...
Autores principales: | Iseki, Tatou, Imai, Yuzuru, Hattori, Nobutaka |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9856048/ https://www.ncbi.nlm.nih.gov/pubmed/36671564 http://dx.doi.org/10.3390/biom13010178 |
Ejemplares similares
-
Lipids: Key Players That Modulate α-Synuclein Toxicity and Neurodegeneration in Parkinson’s Disease
por: Mori, Akio, et al.
Publicado: (2020) -
A Novel LRRK2 Variant p.G2294R in the WD40 Domain Identified in Familial Parkinson’s Disease Affects LRRK2 Protein Levels
por: Ogata, Jun, et al.
Publicado: (2021) -
Twin CHCH Proteins, CHCHD2, and CHCHD10: Key Molecules of Parkinson’s Disease, Amyotrophic Lateral Sclerosis, and Frontotemporal Dementia
por: Imai, Yuzuru, et al.
Publicado: (2019) -
Pathophysiological evaluation of the LRRK2 G2385R risk variant for Parkinson’s disease
por: Tezuka, Toshiki, et al.
Publicado: (2022) -
Models for LRRK2-Linked Parkinsonism
por: Li, Tianxia, et al.
Publicado: (2011)